Drugs Made In America Acquisition II Corp. (DMII)
NASDAQ: DMII · Real-Time Price · USD
10.02
-0.01 (-0.10%)
Dec 5, 2025, 4:00 PM EST - Market closed
DMII Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2024 |
| Dec '24 Dec 31, 2024 |
| Cash & Equivalents | 0.02 |
| Cash & Short-Term Investments | 0.02 |
| Prepaid Expenses | 0.04 |
| Total Current Assets | 0.06 |
| Long-Term Deferred Charges | 0.08 |
| Short-Term Debt | 0.25 |
| Other Current Liabilities | 0 |
| Total Current Liabilities | 0.25 |
| Common Stock | 0 |
| Additional Paid-In Capital | 0.03 |
| Retained Earnings | -0.15 |
| Total Liabilities & Equity | 0.14 |
| Total Debt | 0.25 |
| Net Cash (Debt) | -0.23 |
| Working Capital | -0.2 |
| Tangible Book Value | -0.12 |
Source: S&P Capital IQ. Standard template.
Financial Sources.